These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7103950)

  • 1. Purification and partial characterization of another form of the antiviral protein from the seeds of Phytolacca americana L. (pokeweed).
    Barbieri L; Aron GM; Irvin JD; Stirpe F
    Biochem J; 1982 Apr; 203(1):55-9. PubMed ID: 7103950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pokeweed antiviral protein inactivates pokeweed ribosomes; implications for the antiviral mechanism.
    Bonness MS; Ready MP; Irvin JD; Mabry TJ
    Plant J; 1994 Feb; 5(2):173-83. PubMed ID: 8148876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and properties of new ribosome-inactivating proteins with RNA N-glycosidase activity.
    Bolognesi A; Barbieri L; Abbondanza A; Falasca AI; Carnicelli D; Battelli MG; Stirpe F
    Biochim Biophys Acta; 1990 Nov; 1087(3):293-302. PubMed ID: 2248976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of translational inhibitors from Phytolacca americana. Amino-terminal sequence determination and antibody-inhibitor conjugates.
    Bjorn MJ; Larrick J; Piatak M; Wilson KJ
    Biochim Biophys Acta; 1984 Oct; 790(2):154-63. PubMed ID: 6091760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of four type-1 ribosome-inactivating proteins, with polynucleotide:adenosine glycosidase activity, from leaves of Phytolacca dioica L.
    Di Maro A; Valbonesi P; Bolognesi A; Stirpe F; De Luca P; Siniscalco Gigliano G; Gaudio L; Delli Bovi P; Ferranti P; Malorni A; Parente A
    Planta; 1999 Mar; 208(1):125-31. PubMed ID: 10213004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and partial characterization of single-chain ribosome-inactivating proteins from the seeds of Phytolacca dioica L.
    Parente A; De Luca P; Bolognesi A; Barbieri L; Battelli MG; Abbondanza A; Sande MJ; Gigliano GS; Tazzari PL; Stirpe F
    Biochim Biophys Acta; 1993 Oct; 1216(1):43-9. PubMed ID: 8218414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic clones encoding two isoforms of pokeweed antiviral protein in seeds (PAP-S1 and S2) and the N-glycosidase activities of their recombinant proteins on ribosomes and DNA in comparison with other isoforms.
    Honjo E; Dong D; Motoshima H; Watanabe K
    J Biochem; 2002 Feb; 131(2):225-31. PubMed ID: 11820936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cDNA cloning and expression of pokeweed antiviral protein from seeds in Escherichia coli and its inhibition of protein synthesis in vitro.
    Poyet JL; Hoeveler A
    FEBS Lett; 1997 Apr; 406(1-2):97-100. PubMed ID: 9109394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosome-inactivating proteins from plant cells in culture.
    Barbieri L; Bolognesi A; Cenini P; Falasca AI; Minghetti A; Garofano L; Guicciardi A; Lappi D; Miller SP; Stirpe F
    Biochem J; 1989 Feb; 257(3):801-7. PubMed ID: 2930487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of monoclonal antibodies against the ribosome-inactivating protein PAP from Phytolacca americana.
    Desvoyes B; Dulieu P; Poyet JL; Adami P
    Hybridoma; 1995 Dec; 14(6):571-5. PubMed ID: 8770645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a cDNA clone encoding the pokeweed antiviral protein II from Phytolacca americana and its expression in E. coli.
    Poyet JL; Radom J; Hoeveler A
    FEBS Lett; 1994 Jun; 347(2-3):268-72. PubMed ID: 8034016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level expression and purification of biologically active recombinant pokeweed antiviral protein.
    Rajamohan F; Engstrom CR; Denton TJ; Engen LA; Kourinov I; Uckun FM
    Protein Expr Purif; 1999 Jul; 16(2):359-68. PubMed ID: 10419833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dodecandrin, a new ribosome-inhibiting protein from Phytolacca dodecandra.
    Ready MP; Adams RP; Robertus JD
    Biochim Biophys Acta; 1984 Dec; 791(3):314-9. PubMed ID: 6440592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a Saponaria officinalis seed ribosome-inactivating protein: immunoreactivity and sequence homologies.
    Lappi DA; Esch FS; Barbieri L; Stirpe F; Soria M
    Biochem Biophys Res Commun; 1985 Jun; 129(3):934-42. PubMed ID: 3925952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal deletion mutant of pokeweed antiviral protein inhibits viral infection but does not depurinate host ribosomes.
    Tumer NE; Hwang DJ; Bonness M
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3866-71. PubMed ID: 9108070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree).
    Stirpe F; Gasperi-Campani A; Barbieri L; Falasca A; Abbondanza A; Stevens WA
    Biochem J; 1983 Dec; 216(3):617-25. PubMed ID: 6667259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-terminal deletions on the activity of pokeweed antiviral protein expressed in E. coli.
    Xu J; Meng AX; Hefferon KL; Ivanov IG; Abouhaidar MG
    Biochimie; 1998 Dec; 80(12):1069-76. PubMed ID: 9924987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ribosome-inactivating protein from Amaranthus viridis.
    Kwon SY; An CS; Liu JR; Paek KH
    Biosci Biotechnol Biochem; 1997 Sep; 61(9):1613-4. PubMed ID: 9339569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a biological inactive complex form of pokeweed antiviral protein.
    Desvoyes B; Poyet JL; Schlick JL; Adami P; Jouvenot M; Dulieu P
    FEBS Lett; 1997 Jun; 410(2-3):303-8. PubMed ID: 9237651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials.
    Myers DE; Irvin JD; Smith RS; Kuebelbeck VM; Uckun FM
    J Immunol Methods; 1991 Feb; 136(2):221-37. PubMed ID: 1705571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.